Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2150 of 3546 entries
View as:

First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699

Phase: N/A Priority: Normal
NCT ID: NCT03426995 Org: User:
Start: 03/13/18 End: 05/02/19 Due: 05/02/20

A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT05838755 Org: User:
Start: 09/20/23 End: 02/17/25 Due: 02/17/26

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Phase: N/A Priority: Normal
NCT ID: NCT00586612 Org: User:
Start: 12/01/07 End: 12/30/08 Due: 12/30/09

Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01827644 Org: User:
Start: 04/24/13 End: 07/12/13 Due: 07/12/14

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT03433482 Org: User:
Start: 08/30/18 End: 12/17/19 Due: 12/17/20

Special Drug Use Investigation for LAMICTAL® (Long Term)

Phase: N/A Priority: Normal
NCT ID: NCT01863602 Org: User:
Start: 04/30/09 End: 07/31/16 Due: 07/31/17

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057

Phase: N/A Priority: Normal
NCT ID: NCT01587807 Org: User:
Start: 03/28/12 End: 11/19/12 Due: 11/19/13

GSK2983559 First Time in Human Study

Phase: N/A Priority: Normal
NCT ID: NCT03358407 Org: User:
Start: 01/11/18 End: 02/19/19 Due: 02/19/20

A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01751113 Org: User:
Start: 02/28/13 End: 11/30/13 Due: 11/30/14

A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.

Phase: N/A Priority: Normal
NCT ID: NCT01607385 Org: User:
Start: 05/18/12 End: 12/03/12 Due: 12/03/13

A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01648179 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00697554 Org: User:
Start: 01/31/00 End: - Due: -

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00968539 Org: User:
Start: 09/08/09 End: 09/28/10 Due: 09/28/11

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00938392 Org: User:
Start: 07/30/09 End: 10/05/09 Due: 10/05/10

Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00144859 Org: User:
Start: 07/31/05 End: - Due: -

Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.

Phase: N/A Priority: Normal
NCT ID: NCT00551473 Org: User:
Start: 05/31/07 End: - Due: -

Study to Assess GW642444 in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00381667 Org: User:
Start: 08/31/06 End: 01/31/07 Due: 01/31/08

A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

Phase: N/A Priority: Normal
NCT ID: NCT00848965 Org: User:
Start: 10/31/07 End: 01/31/08 Due: 01/31/09

Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry

Phase: N/A Priority: Normal
NCT ID: NCT01345266 Org: User:
Start: 02/01/10 End: 06/28/10 Due: 06/28/11

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00530790 Org: User:
Start: 08/23/07 End: 02/01/08 Due: 02/01/09

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00073008 Org: User:
Start: 11/30/03 End: 07/31/08 Due: 07/31/09

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00603382 Org: User:
Start: 12/01/07 End: 10/02/08 Due: 10/02/09

Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04114656 Org: User:
Start: 10/15/19 End: 09/16/21 Due: 09/16/22

Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00370435 Org: User:
Start: 08/31/05 End: 09/30/05 Due: 09/30/06

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00289770 Org: User:
Start: 11/01/04 End: 12/20/04 Due: 12/20/05